Clinical Trials Browser

Completed × Triple Negative Breast Neoplasms × capivasertib × Clear all

NCT02423603 2025-03-10

PAKT

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms